Related Experiment Videos
Human SPRY2 inhibits FGF2 signalling by a secreted factor
J Glienke1, G Fenten, M Seemann
1Research Laboratories, Schering AG, Experimental Oncology, Müllerstrasse 178, D-13342, Berlin, Germany.
Mechanisms of Development
|August 15, 2000
Summary
SPRY2, a human Spry homolog, regulates fibroblast growth factor (FGF) signaling. It indirectly inhibits FGF2-stimulated proliferation by controlling the secretion of an FGF inhibitor.
Area of Science:
- Cellular and Molecular Biology
- Developmental Biology
- Signaling Pathways
Background:
- Growth factor signaling pathways are crucial for vertebrate and invertebrate development.
- Spry proteins act as negative regulators of fibroblast growth factor (FGF) signaling.
- The precise role of human SPRY2 in FGF signaling remains largely uncharacterized.
Purpose of the Study:
- To investigate the function of the human SPRY2 gene in fibroblast growth factor 2 (FGF2) signaling.
- To elucidate the mechanism by which SPRY2 influences cell proliferation.
Main Methods:
- Quantitative analysis of SPRY2 mRNA expression in human microvascular endothelial cells (MVEC) upon FGF2 stimulation.
- Overexpression of SPRY2 in A375 cells and assessment of secreted factors' effects on MVEC proliferation.
- Investigation of SPRY2 protein localization using SPRY2/GFP fusion proteins and interaction studies with GRB2.
Main Results:
- FGF2 stimulation transiently upregulates SPRY2 mRNA in MVEC.
- SPRY2 overexpression induces secretion of a factor inhibiting FGF2- but not VEGF-stimulated MVEC proliferation.
- SPRY2 protein interacts with GRB2 and localizes intracellularly, suggesting a role in non-cell autonomous inhibition.
Conclusions:
- SPRY2 plays an indirect role in the non-cell autonomous inhibition of FGF2 signaling.
- SPRY2 regulates the secretion of an FGF inhibitor, impacting vertebrate development.
- This study provides the first evidence of SPRY2's involvement in regulating FGF2 signaling pathways in vertebrates.